94-year-old Wade Gladden came to UAB with only 20 percent heart function, but physicians put a monthslong plan in place to restore function — and the Gadsden resident hit every mark along the way.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
The UAB-HudsonAlpha Center for Genomic Medicine has awarded its first pilot grants to teams of researchers from the two institutions to pursue projects in cancer and cardiac disease.
Lower blood pressure target of 120 mm Hg greatly reduces cardiovascular complications and deaths in older adults.
UAB Hospital is the only Disease-Specific Certified program in Alabama and has had no observations or findings by The Joint Commission since joining the certification process.
Deadlines for abstracts are set for early fall and are open to graduate students, postdoctoral fellows, clinical fellows and residents.
Four projects were awarded through the first School of Medicine AMC21 Reload Multi-Investigator Grants, a broad funding opportunity provided through the Academic Enrichment Fund that enables faculty members to organize and integrate multi-disciplinary teams of accomplished investigators to compete successfully for long-term extramural support.
The protective effect is achieved by reducing acute inflammation in the spleen and the left ventricle of the heart.
UAB will receive funding from the AHA over the next four years to complete projects in population health, clinical and basic science, focused on high blood pressure.
Jennifer Pollock, Ph.D., recently received the Bodil M. Schmidt-Nielsen Distinguished Mentor and Scientist Award from the American Physiological Society.